ApprovalTrail

Natural health product · NPN 80062800

Mito2Max

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed July 17, 2015; licence last revised November 22, 2021.
Natural Product Number (NPN)
80062800
Dosage form
Capsule
Route
Oral
Licensing route
Non-Traditional
First licensed
July 17, 2015
Licence last revised
November 22, 2021

Medicinal ingredients

Per dosage unit, as licensed.

IngredientAmount
(2R)-2-(Acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium inner salt300 milligrams
2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl25 milligrams
Withania somnifera10 milligrams
DL-alpha-Lipoic acid25 milligrams
Litchi chinensis25 milligrams
Litchi chinensis25 milligrams
Litchi chinensis25 milligrams
3,3',4',5,7-Pentahydroxyflavone25 milligrams
3,3',4',5,7-Pentahydroxyflavone25 milligrams
Ophiocordyceps sinensis20 milligrams
Panax quinquefolius20 milligrams

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

  • Source of antioxidants that help protect against or reduce the oxidative damage caused by free radicals. Plays a vital role in energy production. Supports energy production. Helps in cellular energy production. An essential factor in the production of cellular energy in the mitochondria.

Non-medicinal ingredients

Stearic Acid; Microcrystalline cellulose; Maltodextrin; Hydroxypropyl MethylCellulose; Magnesium Stearate; Silicon dioxide